p53 and cyclin D1 staining patterns of malignant and premalignant oral lesions in age-dependent populations

Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics

Volumn 88, Issue 3, 1999, Pages 326-332

  Castle, James T ^a,b   Cardinali, Massimo ^c,d   Kratochvil, F James ^e   Abbondanzo, Susan L ^f   Kessler, Harvey P ^f   Auclair, Paul L ^a   Yeudall, W Andrew ^g  

^a WALTER REED ARMY MEDICAL CENTER   (United States)

^b ARMED FORCES INSTITUTE OF PATHOLOGY   (United States)

^c NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

^d CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^e OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^f UNIVERSITY OF FLORIDA COLLEGE OF DENTISTRY   (United States)

^g GUY S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D1; PROTEIN P53; TUMOR PROTEIN;

ADULT; AGE; AGED; ARTICLE; CHEMISTRY; CHI SQUARE DISTRIBUTION; ENZYME IMMUNOASSAY; FEMALE; GENETICS; HUMAN; IMMUNOLOGY; MALE; METABOLISM; MIDDLE AGED; MOUTH TUMOR; PRECANCER; SQUAMOUS CELL CARCINOMA;

ADULT; AGE FACTORS; AGED; CARCINOMA, SQUAMOUS CELL; CHI-SQUARE DISTRIBUTION; CYCLIN D1; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MIDDLE AGED; MOUTH NEOPLASMS; NEOPLASM PROTEINS; PRECANCEROUS CONDITIONS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0033195188     PISSN: 10792104     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1079-2104(99)70037-5     Document Type: Article

References (37)

1. Cancer incidence in the five continents. Vol. VI. Lyon: IARC Scientific Publications; 1992. No. 120.
2. Jin Y, Heim S, Mandahl N, Bjorklund A, Wennerberg J, Mitelman F. Unrelated clonal chromosome aberrations in carcinomas of the oral cavity. Genes Chromosomes Cancer 1990;1:209-15.
3. Owens W, Field JK, Howard P, Stell PM. Multiple cytogenetic aberrations in squamous cell carcinomas of the head and neck. Oral Oncol Eur J Cancer 1992;28B:17-21.
4. Patel V, Yeudall WA, Gardner AM, Mutlu S, Scully C, Prime SS. Consistent chromosomal anomalies in keratinocyte cell lines derived from untreated malignant lesions of the oral cavity. Genes Chromosomes Cancer 1993;7:109-15.
5. Ah-See KW, Cooke TG, Pickford IR, Soutar D, Balmain A. An allelotype of squamous cell carcinoma of the head and neck using microsatellite markers. Cancer Res 1994;54:1617-21.
6. Nawroz H, van der Riet P, Hruban RH, Koch W, Ruppert JM, Sidransky D. Allelotype of head and neck squamous cell carcinoma. Cancer Res 1994;54:1152-5.
7. Yeudall WA, Crawford RY, Ensley JF, Robbins KC. MTS1/CDK4I is altered in cell lines derived from primary and metastatic oral squamous cell carcinoma. Carcinogenesis 1994;15:2683-6.
8. Merlo A, Herman JG, Mao L, Lee DJ, Gabrielson E, Burger PC, et al. 5′ CpG island methylation is associated with transcriptional silencing of the tumor suppressor p16/CDKN2/MTS1 in human cancers. Nat Med 1995;1:686-92.
9. Loughran O, Malliri A, Owens D, Gallimore PH, Stanley MA, Ozanne B, et al. Association of CDKN2A/p16INK4A with human head and neck keratinocyte replicative senescence: relationship of dysfunction to immortality and neoplasia. Oncogene 1996;13:561-8.
10. Gusterson BA, Anbazhagan R, Warren W, Midgely C, Lane DP, O'Hare M, et al. Expression of p53 in premalignant and malignant squamous epithelium. Oncogene 1991;6:1785-9.
11. Burns JE, Baird MC, Clark LJ, Burns PA, Edington K, Chapman C, et al. Gene mutations and increased levels of p53 protein in human squamous cell carcinomas and their cell lines. Br J Cancer 1993;67:1274-84.
12. Yeudall WA, Paterson IC, Patel V, Prime SS. Presence of human papillomavirus sequences in tumor-derived human oral keratinocytes expressing mutant p53. Oral Oncol Eur J Cancer 1995;31B:136-43.
13. Yeudall WA, Jakus J, Ensley JF, Robbins KC. Functional characterization of p53 molecules expressed in human squamous cell carcinomas of the head and neck. Mol Carcinog 1997;18:89-96.
14. Cardinali M, Kratochvil FJ, Ensley JF, Robbins KC, Yeudall WA. Functional characterization in vivo of mutant p53 molecules derived from squamous cell carcinomas of the head and neck. Mol Carcinog 1997;18:78-88.
15. Loughran O, Edington KG, Berry IJ, Clark LJ, Parkinson EK. Loss of heterozygosity of chromosome 9p21 is associated with the immortal phenotype of neoplastic human head and neck keratinocytes. Cancer Res 1994;54:5045-9.
16. Lammie GA, Fantl V, Smith R, Schuuring E, Brookes S, Michalides R, et al. D11S287, a putative oncogene on chromosome 11q13, is amplified and expressed in squamous cell and mammary carcinomas and linked to BCL-1. Oncogene 1991;6:439-44.
17. Bartkova J, Lukas J, Muller H, Strauss M, Gusterson B, Bartek J. Abnormal patterns of D-type cyclin expression and G1 regulation in human head and neck cancer. Cancer Res 1995;55:949-56.
18. Michalides R, van Veelen N, Hart A, Loftus B, Wientjens E, Balm A. Overexpression of cyclin D1 correlates with recurrence in a group of forty-seven operable squamous cell carcinomas of the head and neck. Cancer Res 1995;55:975-8.
19. Hinds PW, Dowdy SF, Eaton EN, Arnold A, Weinberg RA. Function of a human cyclin gene as an oncogene. Proc Natl Acad Sci U S A 1994;91:709-13.
20. Henk JM, Langdon JD, editors. Malignant tumors of the oral cavity. London: Edward Arnold; 1985. p. 86-7.
21. Boyle P, Zheng T, MacFarlane GJ, McGinn R, Maisonneuve P, LaVecchia C, et al. Recent advances in the etiology and epidemiology of head and neck cancer. Curr Opin Oncol 1990;2:539-45.
22. Macfarlane GJ, Zheng T, Marshall JR, Boffetta P, Niu S, Brasure J, et al. Alcohol, tobacco, diet and the risk of oral cancer: a pooled analysis of three case-control studies. Oral Oncol Eur J Cancer 1995;31B:181-7.
23. Field JK, Spandidos DA, Malliri A, Gosney JR, Yiagnisis M, Stell PM. Elevated p53 expression correlates with a history of heavy smoking in squamous cell carcinoma of the head and neck. Br J Cancer 1991;64:573-7.
24. Field JK, Spandidos DA, Stell PM. Overexpression of p53 gene in head and neck cancer, linked with heavy smoking and drinking. Lancet 1992;339:502-3.
25. Matthews JB, Scully C, Jovanovic A, van der Waal I, Yeudall WA, Prime SS. Relationship of tobacco/alcohol use to p53 expression in patients with lingual squamous cell carcinomas. Oral Oncol Eur J Cancer 1993;29B:285-9.
26. Warnakulasuriya KAAS, Johnson NW. Expression of p53 nuclear phosphoprotein in oral carcinoma and potentially malignant oral lesions. J Oral Pathol Med 1992;21:404-8.
27. Ogden OR, Kiddie RA, Lunnie DP, Lane DP. Assessment of p53 protein expression in normal, benign and malignant oral mucosa. J Pathol 1992;166:389-94.
28. Coltrera MD, Zarbo RJ, Sakr WA, Gown AM. Markers for dysplasia of the upper aerodigestive tract: suprabasal expression of PCNA, p53, and CK19 in alcohol-fixed, embedded tissue. Am J Pathol 1992;141:817-25.
29. Levine AJ. The tumor suppressor genes. Annu Rev Biochem 1993;62:623-51.
30. El-Deiry WS, Harper JW, O'Connor PM. Velculescu VE, Canman CE, Jackman J, et al. WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis. Cancer Res 1994;54:1169-74.
31. Adler-Storthz K, Newland JR, Tessin BA, Yeudall WA, Shillitoe EJ. HPV2 DNA in oral verrucous carcinoma. J Oral Pathol 1986;15:472-5.
32. Maitland NJ, Bromidge T, Cox MF, Crane IJ, Prime SS, Scully C. Detection of human papillomavirus genes in human oral tissue biopsies and cultures by polymerase chain reaction. Br J Cancer 1989;59:698-702.
33. Yeudall WA, Campo MS. Human papillomavirus DNA in biopsies of oral tissues. J Gen Virol 1991;72:173-6.
34. Scheffner M, Werness BA, Huibregtse JM, Levine AJ, Howley PM. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 1991;63:1129-36.
35. Sarnow P, Ho YS, Williams J, Levine AJ. The adenovirus E1b-55Kd tumor antigen and SV40 large tumor antigen are physically associated with the same 54K cellular protein. Cell 1982;28:387-94.
36. Lane DP, Crawford LV. T antigen is bound to a host protein in SV40-transformed cells. Nature 1979;278:261-3.
37. Carbone M, Rizzo P, Grimley PM, Procopio A, Mew DJ, Shridhar V, et al. Simian virus-40 large-T antigen binds p53 in human mesotheliomas. Nat Med 1997;3:908-12.